Kymera Therapeutics Inc. – Filings and Transcripts

NASDAQ: KYMR
Share price (9/24/26): $115.81
Market cap (9/24/26): $9.630 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Price T Rowe Associates Inc

Chadwick Jeremy G

Price T Rowe Associates Inc

News Filter

Announces Second Quarter 2026 Financial Results and Provides a Business Update

Appoints Terence Rooney, MD, as Chief Medical Officer

Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis With Topline Data by Year-End 2026

Shareholder Vote Results

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Scanned paper annual report submission

Letter from the SEC